Consensus Egetis Therapeutics AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:59 2024-05-02 am EDT			5-day change	1st Jan Change
6.96 ^SEK	+9.09%		+10.83%	+24.73%

Feb. 22	Egetis Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 22	Egetis Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

54bbb2cf03.6VsZV6ysFpjw-szDrn_mvAH1soMjlTZHTO3jaOs9Bi4.2m58As_AQNuSuZmVyjGB2niXyLpm0WIJda6pDt9edGGhGC4ym-l6qbHPmQ~7029fcf7928ab1a23f91ea669497bd6f

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.96 SEK

Average target price

13.12 SEK

Spread / Average Target

+88.58%

High Price Target

17.5 SEK

Spread / Highest target

+151.44%

Low Price Target

11 SEK

Spread / Lowest Target

+58.05%

Trading Rating

Investor Rating

ESG Refinitiv